Epicardial adipose tissue volume highly correlates with left ventricular diastolic dysfunction in endogenous Cushing’s syndrome

References

• Gadelha M, Gatto F, Wildemberg LE, et al. Cushing’s syndrome. Lancet. 2023;402(10418):2237–2252. doi: 10.1016/S0140-6736(23)01961-X.
   PubMed Web of Science ®Google Scholar
• Pivonello R, Isidori AM, De Martino MC, et al. Complications of Cushing’s syndrome: state of the art. Lancet Diabetes Endocrinol. 2016;4(7):611–629. doi: 10.1016/S2213-8587(16)00086-3.
   PubMed Web of Science ®Google Scholar
• Kanzaki A, Kadoya M, Katayama S, et al. Cardiac hypertrophy and related dysfunctions in Cushing syndrome patients-literature review. J Clin Med. 2022;11(23):7035. doi: 10.3390/jcm11237035.
   PubMed Web of Science ®Google Scholar
• Dekkers OM, Horváth-Puhó E, Jørgensen JOL, et al. Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. J Clin Endocrinol Metab. 2013;98(6):2277–2284. doi: 10.1210/jc.2012-3582.
   PubMed Web of Science ®Google Scholar
• Fardet L, Petersen I, Nazareth I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing’s syndrome: cohort study. BMJ. 2012;345:e4928. doi: 10.1136/bmj.e4928.
   PubMed Web of Science ®Google Scholar
• Moustaki M, Markousis-Mavrogenis G, Vryonidou A, et al. Cardiac disease in Cushing’s syndrome. Emphasis on the role of cardiovascular magnetic resonance imaging. Endocrine. 2023;83(3):548–558. doi: 10.1007/s12020-023-03623-0.
   PubMed Web of Science ®Google Scholar
• Kosmala W, Marwick TH. Asymptomatic left ventricular diastolic dysfunction: predicting progression to symptomatic heart failure. JACC Cardiovasc Imaging. 2020;13(1 Pt 2):215–227. doi: 10.1016/j.jcmg.2018.10.039.
   PubMed Web of Science ®Google Scholar
• Muiesan ML, Lupia M, Salvetti M, et al. Left ventricular structural and functional characteristics in Cushing’s syndrome. J Am Coll Cardiol. 2003;41(12):2275–2279. doi: 10.1016/s0735-1097(03)00493-5.
   PubMed Web of Science ®Google Scholar
• Chin SO, Rhee SY, Chon S, et al. Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. PLoS One. 2013;8(3):e60119. doi: 10.1371/journal.pone.0060119.
   PubMed Web of Science ®Google Scholar
• Fang H, Berg E, Cheng X, et al. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018;21(5):360–365. doi: 10.1097/MCO.0000000000000485.
   PubMed Web of Science ®Google Scholar
• Delivanis DA, Iñiguez-Ariza NM, Zeb MH, et al. Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas. Clin Endocrinol (Oxf). 2018;88(2):209–216. doi: 10.1111/cen.13512.
   PubMed Web of Science ®Google Scholar
• Schakman O, Kalista S, Barbé C, et al. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol. 2013;45(10):2163–2172. doi: 10.1016/j.biocel.2013.05.036.
   PubMed Web of Science ®Google Scholar
• Canepa M, Strait JB, Milaneschi Y, et al. The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging. Nutr Metab Cardiovasc Dis. 2013;23(12):1263–1270. doi: 10.1016/j.numecd.2013.04.003.
   PubMed Web of Science ®Google Scholar
• Ko B-J, Chang Y, Kang JG, et al. Low relative muscle mass and left ventricular diastolic dysfunction in middle-aged adults. Int J Cardiol. 2018;255:118–123. doi: 10.1016/j.ijcard.2017.07.089.
   PubMed Web of Science ®Google Scholar
• Villasante Fricke AC, Iacobellis G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int J Mol Sci. 2019;20(23):5989. doi: 10.3390/ijms20235989.
   PubMed Web of Science ®Google Scholar
• de Wit-Verheggen VHW, Altintas S, Spee RJM, et al. Pericardial fat and its influence on cardiac diastolic function. Cardiovasc Diabetol. 2020;19(1):129. doi: 10.1186/s12933-020-01097-2.
   PubMed Web of Science ®Google Scholar
• Park HE, Choi SY, Kim M. Association of epicardial fat with left ventricular diastolic function in subjects with metabolic syndrome: assessment using 2-dimensional echocardiography. BMC Cardiovasc Disord. 2014;14(1):3. doi: 10.1186/1471-2261-14-3.
   PubMedGoogle Scholar
• Moody AJ, Molina-Wilkins M, Clarke GD, et al. Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes. Diabetes Obes Metab. 2023;25(2):426–434. doi: 10.1111/dom.14885.
   PubMed Web of Science ®Google Scholar
• Maurice F, Gaborit B, Vincentelli C, et al. Cushing syndrome is associated with subclinical LV dysfunction and increased epicardial adipose tissue. J Am Coll Cardiol. 2018;72(18):2276–2277. doi: 10.1016/j.jacc.2018.07.096.
   PubMed Web of Science ®Google Scholar
• Wolf P, Marty B, Bouazizi K, et al. Epicardial and pericardial adiposity without myocardial steatosis in Cushing syndrome. J Clin Endocrinol Metab. 2021;106(12):3505–3514. doi: 10.1210/clinem/dgab556.
   PubMed Web of Science ®Google Scholar
• Wang M, Qin L, Bao W, et al. Epicardial and pericoronary adipose tissue and coronary plaque burden in patients with Cushing’s syndrome: a propensity score-matched study. J Endocrinol Invest. 2024;47(8):1995–2005. doi: 10.1007/s40618-023-02295-x.
   PubMed Web of Science ®Google Scholar
• Fleseriu M, Auchus R, Bancos I, et al. Consensus on ­diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9(12):847–875. doi: 10.1016/S2213-8587(21)00235-7.
   PubMed Web of Science ®Google Scholar
• Grodecki K, Lin A, Razipour A, et al. Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19. Metabolism. 2021;115:154436. doi: 10.1016/j.metabol.2020.154436.
   PubMed Web of Science ®Google Scholar
• Yin L, Yan C, Yang C, et al. Measurement of epicardial adipose tissue using non-contrast routine chest-CT: a consideration of threshold adjustment for fatty attenuation. BMC Med Imaging. 2022;22(1):114. doi: 10.1186/s12880-022-00840-3.
   PubMed Web of Science ®Google Scholar
• Derstine BA, Holcombe SA, Ross BE, et al. Healthy US population reference values for CT visceral fat measurements and the impact of IV contrast, HU range, and spinal levels. Sci Rep. 2022;12(1):2374. doi: 10.1038/s41598-022-06232-5.
   PubMed Web of Science ®Google Scholar
• Liu D, Garrett JW, Lee MH, et al. Fully automated CT-based adiposity assessment: comparison of the L1 and L3 vertebral levels for opportunistic prediction. Abdom Radiol (NY). 2023;48(2):787–795. doi: 10.1007/s00261-022-03728-6.
   PubMed Web of Science ®Google Scholar
• Liu S, Han X, Li J, et al. Feasibility of using chest computed tomography (CT) imaging at the first lumbar vertebra (L1) level to assess skeletal muscle mass: a retrospective study. PeerJ. 2023;11:e16652. doi: 10.7717/peerj.16652.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270. doi: 10.1093/ehjci/jev014.
   PubMed Web of Science ®Google Scholar
• Oh JK, Hatle L, Tajik AJ, et al. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol. 2006;47(3):500–506. doi: 10.1016/j.jacc.2005.09.032.
   PubMed Web of Science ®Google Scholar
• Geer EB, Shen W, Gallagher D, et al. MRI assessment of lean and adipose tissue distribution in female patients with Cushing’s disease. Clin Endocrinol (Oxf). 2010;73(4):469–475. doi: 10.1111/j.1365-2265.2010.03829.x.
   PubMed Web of Science ®Google Scholar
• Gruzdeva O, Borodkina D, Uchasova E, et al. Localization of fat depots and cardiovascular risk. Lipids Health Dis. 2018;17(1):218. doi: 10.1186/s12944-018-0856-8.
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Ross R, Després J-P, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715–725. doi: 10.1016/S2213-8587(19)30084-1.
   PubMed Web of Science ®Google Scholar
• Damluji AA, Alfaraidhy M, AlHajri N, et al. Sarcopenia and cardiovascular diseases. Circulation. 2023;147(20):1534–1553. doi: 10.1161/CIRCULATIONAHA.123.064071.
   PubMed Web of Science ®Google Scholar
• Yuan S, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533. doi: 10.1016/j.metabol.2023.155533.
   PubMed Web of Science ®Google Scholar
• Nagueh SF. Left ventricular diastolic function: understanding pathophysiology, diagnosis, and prognosis with echocardiography. JACC Cardiovasc Imaging. 2020;13(1 Pt 2):228–244. doi: 10.1016/j.jcmg.2018.10.038.
   PubMed Web of Science ®Google Scholar
• Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289(2):194–202. doi: 10.1001/jama.289.2.194.
   PubMed Web of Science ®Google Scholar
• Fontes-Carvalho R, Fontes-Oliveira M, Sampaio F, et al. Influence of epicardial and visceral fat on left ventri­cular diastolic and systolic functions in patients after myocardial infarction. Am J Cardiol. 2014;114(11):1663–1669. doi: 10.1016/j.amjcard.2014.08.037.
   PubMed Web of Science ®Google Scholar
• Sawada N, Daimon M, Kawata T, et al. The significance of the effect of visceral adiposity on left ventricular diastolic function in the general population. Sci Rep. 2019;9(1):4435. doi: 10.1038/s41598-018-37137-x.
   PubMedGoogle Scholar
• Lin HH, Lee JK, Yang CY, et al. Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis. Cardiovasc Diabetol. 2013;12(1):127. doi: 10.1186/1475-2840-12-127.
   PubMedGoogle Scholar
• Nerlekar N, Muthalaly RG, Wong N, et al. Association of volumetric epicardial adipose tissue quantification and cardiac structure and function. J Am Heart Assoc. 2018;7(23):e009975. doi: 10.1161/JAHA.118.009975.
   PubMed Web of Science ®Google Scholar
• Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19(9):593–606. doi: 10.1038/s41569-022-00679-9.
   PubMed Web of Science ®Google Scholar
• Nakanishi K, Fukuda S, Tanaka A, et al. Relationships between periventricular epicardial adipose tissue accumulation, coronary microcirculation, and left ventricular diastolic dysfunction. Can J Cardiol. 2017;33(11):1489–1497. doi: 10.1016/j.cjca.2017.08.001.
   PubMed Web of Science ®Google Scholar
• Wu C-K, Tsai H-Y, Su M-YM, et al. Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients. J Clin Lipidol. 2017;11(6):1421–1431. doi: 10.1016/j.jacl.2017.08.018.
   PubMed Web of Science ®Google Scholar
• Park J-H, Park YS, Kim YJ, et al. Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe. J Cardiovasc Ultrasound. 2010;18(4):121–126. doi: 10.4250/jcu.2010.18.4.121.
   PubMedGoogle Scholar
• Morano S, Romagnoli E, Filardi T, et al. Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study. Acta Diabetol. 2015;52(4):727–732. doi: 10.1007/s00592-014-0710-z.
   PubMed Web of Science ®Google Scholar
• Sato T, Aizawa Y, Yuasa S, et al. The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc Diabetol. 2018;17(1):6. doi: 10.1186/s12933-017-0658-8.
   PubMed Web of Science ®Google Scholar
• Kitterer D, Latus J, Henes J, et al. Impact of long-term steroid therapy on epicardial and pericardial fat deposition: a cardiac MRI study. Cardiovasc Diabetol. 2015;14(1):130. doi: 10.1186/s12933-015-0289-x.
   PubMedGoogle Scholar
• Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2(10):819–829. doi: 10.1016/S2213-8587(14)70034-8.
   PubMed Web of Science ®Google Scholar
• Masiha S, Sundström J, Lind L. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. J Hum Hypertens. 2013;27(1):13–17. doi: 10.1038/jhh.2011.113.
   PubMed Web of Science ®Google Scholar
• Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263–271. doi: 10.1016/j.jacc.2013.02.092.
   PubMed Web of Science ®Google Scholar
• Jung M-H, Ihm S-H, Park SM, et al. Effects of sarcopenia, body mass indices, and sarcopenic obesity on diastolic function and exercise capacity in Koreans. Metabolism. 2019;97:18–24. doi: 10.1016/j.metabol.2019.05.007.
   PubMed Web of Science ®Google Scholar
• Miyajima Y, Toyama T, Mori M, et al. Relationships between kidney dysfunction and left ventricular diastolic dysfunction: a hospital-based retrospective study. J Nephrol. 2021;34(3):773–780. doi: 10.1007/s40620-020-00940-9.
   PubMed Web of Science ®Google Scholar
• Borrelli S, De Nicola L, Garofalo C, et al. Prevalence and renal prognosis of left ventricular diastolic dysfunction in non-dialysis chronic kidney disease patients with preserved systolic function. J Hypertens. 2022;40(4):723–731. doi: 10.1097/HJH.0000000000003069.
   PubMed Web of Science ®Google Scholar
• Sun L, Liu X, Li W, et al. HDL-C to hsCRP ratio is associated with left ventricular diastolic function in absence of significant coronary atherosclerosis. Lipids Health Dis. 2019;18(1):219. doi: 10.1186/s12944-019-1157-6.
   PubMed Web of Science ®Google Scholar
• Horio T, Miyazato J, Kamide K, et al. Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension. Am J Hypertens. 2003;16(11 Pt 1):938–944. doi: 10.1016/s0895-7061(03)01015-x.
   PubMed Web of Science ®Google Scholar
• Thacker SG, Zarzour A, Chen Y, et al. High-density ­lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology. 2016;149(3):306–319. doi: 10.1111/imm.12638.
   PubMed Web of Science ®Google Scholar